HealthQuill Pharma
British pharmaceutical company GSK Plc said a new experimental cancer drug helped patients with a difficult-to-treat type of lung cancer live longer than those who received an existing treatment, according to a company statement.
Drugs Medical Pharma

GSK’s test drug cuts death risk by 54% in patients with small lung cancer relapse

HQ Team September 13, 2026:  British pharmaceutical company GSK Plc said a new experimental cancer drug helped patients with a difficult-to-treat type of.

Read More
AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without the disease progressing or getting worse, according to the Anglo-Swedish company.
Drugs Medical Pharma

AstraZeneca’s test drug for breast cancer fails to prolong life

HQ Team September 13, 2026: AstraZeneca’s end-stage trial of an experimental drug to treat breast cancer failed to prolong a patient’s life without.

Read More
AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key goal in late-stage trials, the company announced.
Drugs Medical Pharma

AbbVie’s late-stage experimental drug reduces menstrual migraine days

HQ Team September 11, 2026: AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key.

Read More
A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses high-intensity sound waves to break down targeted diseased tissue without incisions, heat, or trauma, enabling the body to heal itself naturally.
Drugs Medical Pharma

US-based start-up developing medical device to replace surgical incision

HQ Team September 10, 2026: A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses.

Read More
Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced.
Drugs Medical Pharma

Novartis’s neuromuscular experimental drug fails to meet targets

HQ Team September 9, 2026: Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced. The.

Read More
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.
Pharma

Moderna, Merck’s personalised mRNA vaccine clears Phase 3 in melanoma

HQ Team August 20, 2026: Moderna’s stock more than doubled, surging as much as 177% intraday to $174.38 on Aug. 19, 2026, after.

Read More
An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo at an “unprecedented speed” until every transmission chain is found and broken, Dr Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, said.
Drugs Health Pharma

World still ‘playing catch-up’ with Ebola virus epidemic in Congo: WHO chief

HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo.

Read More
AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination therapy failed to outperform standard treatments for advanced non-small cell lung cancer.
Drugs Health Pharma

AstraZeneca ends late-stage trial of drug to treat non-small cell cancer

HQ Team August 17, 2026: AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination.

Read More
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Pharma

The weight-loss drug race just got crowded

Jay Shankar July 21, 2026: Global obesity medicine sales hit $66 billion in 2025 and are on track to reach $92 billion this.

Read More
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Pharma

FDA expands approval of kidney cancer drug to earlier-stage patients

HQ Team June 16, 2026: The US Food and Drug Administration (FDA) has expanded approval of belzutifan, a first-in-class kidney cancer drug, to.

Read More